Nanotechnology and Mri Contrast Enhancement

• Leff HS , RexAF. Maxwell’s demon 2: entropy, classical and quantum information, computing Institute of Physics, Bristol, PA, USA (2003).
   Google Scholar
• Muller EW . Study of atomic structure of metal surfaces in the field ion microscope.J. Appl. Phys.28, 1–6 (1957).
   Web of Science ®Google Scholar
• Eigler DM , SchweizerEK. Positioning single atoms with a scanning tunneling microscope.Nature344, 524–526 (1990).
   Web of Science ®Google Scholar
• Ferrari M . Cancer nanotechnology: opportunities and challenges.Nat. Rev. Cancer5, 161–171 (2005).
   PubMed Web of Science ®Google Scholar
• Hartman KB , LausS, BolskarRDet al. Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano. Lett. 8, 415–419 (2008).
   PubMed Web of Science ®Google Scholar
• Hämisch Y . Molecular Imaging with PET: new insights into the molecular basis of health and disease.Medicamundi47, 18–27 (2003).
   Google Scholar
• Månsson SB . Physical principles of magnetic imaging by nuclear magnetic resonance. In: The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Merbach A, Toth E (Eds). John Wiley & Sons, Chichester, UK, 1–43 (2001).
   Google Scholar
• de Bazelaire CM , DuhamelGD, RofskyNM, AlsopDC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology230, 652–659 (2004).
   PubMed Web of Science ®Google Scholar
• Hendrick RE , HaackeEM. Basic physics of MR contrast agents and maximization of image-contrast.J. Magn. Reson. Imaging3, 137–148 (1993).
   PubMed Web of Science ®Google Scholar
• Bean CP , LivingstonJD. Superparamagnetism.J. Appl. Phys.30, 120–129 (1959).
   Web of Science ®Google Scholar
• Cacheris WP , QuaySC, RocklageSM. The relationship between thermodynamics and the toxicity of gadolinium complexes.Magn. Reson. Imaging8, 467–481 (1990).
   PubMed Web of Science ®Google Scholar
• Olsvik O , PopovicT, SkjerveEet al. Magnetic separation techniques in diagnostic microbiology. Clin. Microbiol. Rev. 7, 43–54 (1994).
   PubMed Web of Science ®Google Scholar
• Månsson S . Physical principles of magnetic imaging by nuclear magnetic resonance. In: The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Merbach A, Toth E (Eds). Wiley, NY, USA, 1–43 (2001).
   Google Scholar
• Bulte JWM , KraitchmanDL. Iron oxide MR contrast agents for molecular and cellular imaging.NMR Biomed.17, 484–499 (2004).
   PubMed Web of Science ®Google Scholar
• Liu W , FrankJA. Detection and quantification of magnetically labeled cells by cellular MRI.Eur. J. Radiol.70, 258–264 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrucci JT , StarkDD. Iron-oxide enhanced MR-imaging of the liver and spleen – review of the 1st–5 years.Am. J. Roentgenol.155, 943–950 (1990).
   PubMed Web of Science ®Google Scholar
• Pratten MK , LloydJB. Pinocytosis and phagocytosis – the effect of size of a particulate substrate on its mode of capture by rat peritoneal-macrophages cultured in vitro. Biochim. Biophys. Acta881, 307–313 (1986).
   PubMed Web of Science ®Google Scholar
• Rogers WJ , BasuP. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging.Atherosclerosis178, 67–73 (2005).
   PubMed Web of Science ®Google Scholar
• Weissleder R , StarkDD, EngelstadBLet al. Superparamagnetic iron-oxide - pharmacokinetics and toxicity. Am. J. Roentgenol. 152, 167–173 (1989).
   PubMed Web of Science ®Google Scholar
• Saini S , StarkDD, HahnPFet al. Ferrite particles – a superparamagnetic MR contrast agent for enhanced detection of liver-carcinoma. Radiology 162, 217–222 (1987).
   PubMed Web of Science ®Google Scholar
• Lu AH , SalabasEL, SchuthF. Magnetic nanoparticles: Synthesis, protection, functionalization, and application.Angew. Chem. Int. Ed. Engl.46, 1222–1244 (2007).
   PubMed Web of Science ®Google Scholar
• Patri A , DobrovolskaiaM, SternS, McNeilS. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics. In: Nanotechnology for cancer therapy. Amiji MM (Ed.). CRC/Taylor & Francis, Boca Raton, USA, 817 (2007).
   Google Scholar
• Stark DD , WeisslederR, ElizondoGet al. Superparamagnetic iron-oxide – clinical-application as a contrast agent for MR imaging of the liver. Radiology 168, 297–301 (1988).
   PubMed Web of Science ®Google Scholar
• Reimer P , BalzerT. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.Eur. Radiol.13, 1266–1276 (2003).
   PubMed Web of Science ®Google Scholar
• Gruttner C , TellerJ. New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications.J. Magn. Magn. Mater.194, 8–15 (1999).
   Web of Science ®Google Scholar
• Taupitz M , WagnerS, SchnorrJ. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging.Invest. Radiol.39, 625–625 (2004).
   Web of Science ®Google Scholar
• Li W , TuttonS, VuATet al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J. Magn. Reson. Imaging 21, 46–52 (2005).
   PubMed Web of Science ®Google Scholar
• Schulze E , FerrucciJT, PossK, LapointeL, BogdanovaA, WeisslederR. Cellular uptake and trafficking of a prototypical magnetic iron-oxide label in-vitro. Invest. Radiol.30, 604–610 (1995).
   PubMed Web of Science ®Google Scholar
• Huang HC , ChangPY, ChangKet al. Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging. J. Biomed. Sci. 16(1), 86 (2009).
   PubMedGoogle Scholar
• Kim D , HongKS, SongJ. The present status of cell tracking methods in animal models using magnetic resonance imaging technology.Mol. Cell23, 132–137 (2007).
   Google Scholar
• Vogl TJ , HammerstinglR, SchwarzWet al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198, 881–887 (1996).
   PubMed Web of Science ®Google Scholar
• Zheng WW , ZhouKR, ChenZW, ShenJZ, ChenCZ, ZhangSJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI.World J. Gastroenterol.8, 82–86 (2002).
   PubMed Web of Science ®Google Scholar
• Harisinghani MG , SainiS, WeisslederRet al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am. J. Roentgenol. 172, 1347–1351 (1999).
   PubMed Web of Science ®Google Scholar
• Michel SCA , KellerTM, FrohlichJMet al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225, 527–536 (2002).
   PubMed Web of Science ®Google Scholar
• Lee JM , KimIH, KwakHS, YoukJH, HanYM, KimCS. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.Korean J. Radiol.4, 1–8 (2003).
   PubMed Web of Science ®Google Scholar
• Tanimoto A , WakabayashiG, ShinmotoH, NakatsukaS, OkudaS, KuribayashiS. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.J. Gastroenterol.40, 371–380 (2005).
   PubMed Web of Science ®Google Scholar
• Nakamura H , ItoN, KotakeF, MizokamiY, MatsuokaT. Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma.J. Gastroenterol.35, 849–855 (2000).
   PubMed Web of Science ®Google Scholar
• Kudo M . Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions.Semin. Liver Dis.19, 297–309 (1999).
   PubMed Web of Science ®Google Scholar
• Araki T . SPIO-MRI in the detection of hepatocellular carcinoma.J. Gastroenterol.35, 874–876 (2000).
   PubMed Web of Science ®Google Scholar
• Rappeport ED , LoftA, BerthelsenAKet al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol. 48, 369–378 (2007).
   PubMed Web of Science ®Google Scholar
• Rogers WJ , MeyerCH, KramerCM. Technology insight: in vivo cell tracking by use of MRI. Nat. Clin. Pract. Cardiovasc. Med.3, 554–562 (2006).
   PubMedGoogle Scholar
• Krejci J , PachernikJ, HamplA, DvorakP. In vitro labelling of mouse embryonic stem cells with SPIO nanoparticles. Gen. Physiol. Biophys.27, 164–173 (2008).
   PubMed Web of Science ®Google Scholar
• Gao J . MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.Mol. Pharm.7(1), 32–40 (2010).
   PubMedGoogle Scholar
• Huang H , XieQ, KangMet al. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging. Nanotechnology 20, 365101 (2009).
   PubMed Web of Science ®Google Scholar
• Mulder WJM , StrijkersGJ, van Tilborg GAF, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed.19, 142–164 (2006).
   PubMed Web of Science ®Google Scholar
• Tang Z , LinN, FangHet al. MRI tracking of the fate of intravascularly injected and SPIO-labeled rat mesenchymal stem cells in the livers of rats with hepatic fibrosis. Dig. Dis. Sci. DOI: 10.1007/s10620-009-0921-2 (2009) (Epub ahead of print).
   Google Scholar
• Sykova E , JendelovaP. In vivo tracking of stem cells in brain and spinal cord injury. Prog. Brain Res.161, 367–383 (2007).
   PubMed Web of Science ®Google Scholar
• Nowacek A , GendelmanHE. NanoART, neuroAIDS and CNS drug delivery.Nanomed.4, 557–574 (2009).
   PubMed Web of Science ®Google Scholar
• Toma A , OtsujiE, KuriuYet al. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br. J. Cancer 93, 131–136 (2005).
   PubMed Web of Science ®Google Scholar
• Tsourkas A , Shinde-PatilVR, KellyKAet al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug. Chem.16, 576–581 (2005).
   PubMed Web of Science ®Google Scholar
• Bos C , DelmasY, DesmouliereAet al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology233, 781–789 (2004).
   PubMed Web of Science ®Google Scholar
• Frank JA , MillerBR, ArbabASet al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 229, 610–610 (2003).
   PubMed Web of Science ®Google Scholar
• Kawahara I , NakamotoM, KitagawaNet al. Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque. Neurol. Med. Chir. (Tokyo) 48, 157–162 (2008).
   PubMed Web of Science ®Google Scholar
• Marzelli M , FischerK, KimYBet al. Composite MR contrast agents for conditional cell-labeling. Int. J. Imaging Syst. Technol. 18, 79–84 (2008).
   PubMed Web of Science ®Google Scholar
• Yang F , GuAY, ChenZP, GuN, JiM. Multiple emulsion microbubbles for ultrasound imaging.Mater. Lett.62, 121–124 (2008).
   Web of Science ®Google Scholar
• Ji XJ , ShaoRP, ElliottAMet al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J. Phys. Chem. C Nanomater. Interfaces 111, 6245–6251 (2007).
   PubMed Web of Science ®Google Scholar
• Stuber M , GilsonWD, ScharMet al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-Resonant water suppression (IRON). Magn. Reson. Med. 58, 1072–1077 (2007).
   PubMed Web of Science ®Google Scholar
• Zurkiya O , HuXP. Off-resonance saturation as a means of generating contrast with superparamagnetic nanoparticles.Magn. Reson. Med.56, 726–732 (2006).
   PubMed Web of Science ®Google Scholar
• Kroto HW , HeathJR, ObrienSC, CurlRF, SmalleyRE. C-60 – buckminsterfullerene.Nature318, 162–163 (1985).
   Web of Science ®Google Scholar
• Heath JR , ObrienSC, ZhangQet al. Lanthanum complexes of spheroidal carbon shells. J. Am. Chem. Soc. 107, 7779–7780 (1985).
   Web of Science ®Google Scholar
• Laus S , SitharamanB, TothEet al. Understanding paramagnetic relaxation phenomena for water-soluble gadofullerenes. J. Phys. Chem. C Nanomater. Interfaces 111, 5633–5639 (2007).
   Web of Science ®Google Scholar
• Toth E , BolskarRD, BorelAet al. Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J. Am. Chem. Soc. 127, 799–805 (2005).
   PubMed Web of Science ®Google Scholar
• Bertini I , GalasO, LuchinatC, ParigiG. Computer-program for the calculation of paramagnetic enhancements nuclear-relaxation rates in slowly rotating systems.J. Magn. Reson. A113, 151–158 (1995).
   Google Scholar
• Laus S , SitharamanB, TothVet al. Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C60(OH)x and Gd@C60[C(COOH2)]10. J. Am. Chem. Soc. 127, 9368–9369 (2005).
   PubMed Web of Science ®Google Scholar
• Sitharaman B , TranLA, PhamQPet al. Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast Media Mol. Imaging 2, 139–146 (2007).
   PubMed Web of Science ®Google Scholar
• Stevenson S , StephenRR, AmosTM, CadoretteVR, ReidJE, PhillipsJP. Synthesis and purification of a metallic nitride fullerene BisAdduct: exploring the reactivity of Gd3N@C80. J. Am. Chem. Soc.127, 12776–12777 (2005).
   PubMed Web of Science ®Google Scholar
• Lu J , SabirianovRF, MeiWN, GaoY, DuanCG, ZengXC. Structural and magnetic properties of Gd3N@C80. J. Phys. Chem. B.110, 23637–23640 (2006).
   PubMed Web of Science ®Google Scholar
• Stevenson S , PhillipsJP, ReidJE, OlmsteadMM, RathSP, BalchAL. Pyramidalization of Gd3N inside a C-80 cage. The synthesis and structure of Gd3N@C80. Chem. Commun.2814–2815 (2004).
   PubMed Web of Science ®Google Scholar
• MacFarland DK , WalkerKL, LenkRPet al. Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast. J. Med. Chem. 51, 3681–3683 (2008).
   PubMed Web of Science ®Google Scholar
• Chen Z , FatourosPP, CorwinFD, BroaddusWC, DornHC. In vitro and in vivo imaging studies of a new gadolinium endohedral metallofullerene MRI contrast agent. Neuro. Oncol.8, 492–492 (2006).
   Google Scholar
• Fatouros PP , CorwinFD, ChenZJet al. In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology240, 756–764 (2006).
   PubMed Web of Science ®Google Scholar
• Rinzler AG , LiuJ, DaiHet al. Large-scale purification of single-wall carbon nanotubes: process, product, and characterization. Appl. Phys. A Mater. Sci. Processing 67, 29–37 (1998).
   Web of Science ®Google Scholar
• Journet C , MaserWK, BernierPet al. Large-scale production of single-walled carbon nanotubes by the electric-arc technique. Nature 388, 756–758 (1997).
   Web of Science ®Google Scholar
• Nikolaev P , BronikowskiMJ, BradleyRKet al. Gas-phase catalytic growth of single-walled carbon nanotubes from carbon monoxide. Chem. Phys. Lett. 313, 91–97 (1999).
   Web of Science ®Google Scholar
• Gu Z , PengH, HaugeRH, SmalleyRE, MargraveJL. Cutting single-wall carbon nanotubes through fluorination.Nano. Lett.2, 1009–1013 (2002).
   Web of Science ®Google Scholar
• Ashcroft JM , HartmanKB, KissellKRet al. Single-molecule I-2@US tube nanocapsules: a new X-ray contrast-agent design. Adv. Mater. 19, 573 (2007).
   Web of Science ®Google Scholar
• Hartman KB , HamlinDK, WilburDS, WilsonLJ. (AtCl)-At-211@US tube nanocapsules: a new concept in radiotherapeutic-agent design.Small3, 1496–1499 (2007).
   PubMed Web of Science ®Google Scholar
• Sitharaman B , KissellKR, HartmanKBet al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem. Commun. 3915–3917 (2005).
   PubMed Web of Science ®Google Scholar
• Ananta JS , MatsonML, TangAMet al. Single-walled carbon nanotubes materials as T2-weighted MRI contrast agents. J. Phys. Chem. C DOI: 10.1021/jp907891n (2009) (Epub ahead of print).
   Web of Science ®Google Scholar
• Sithararman B , WilsonLJ. Gadonanotubes as new high-performance MRI contrast agents.Int. J. Nanomed.1, 291–295 (2006).
   PubMed Web of Science ®Google Scholar
• Tannock IF , RotinD. Acid pH in tumors and its potential for Therapeutic exploitation.JBR-BTR.49, 4373–4384 (1989).
   Google Scholar
• Striolo A . The mechanism of water diffusion in narrow carbon nanotubes.Nano. Lett.6, 633–639 (2006).
   PubMed Web of Science ®Google Scholar
• Jankovski A , RaftopoulosC, VazGet al. Intra-operative MRI at 3T: short report. JBR-BTR. 90, 249–251 (2007).
   Google Scholar
• McDermott R , LeeSK, ten Haken B, Trabesinger AH, Pines A, Clarke J. Microtesla MRI with a superconducting quantum interference device. Proc. Natl Acad. Sci. USA101, 7857–7861 (2004).
   PubMed Web of Science ®Google Scholar
• Mansfield P . Snapshot magnetic resonance imaging (nobel lecture).Angew. Chem. Int. Ed. Engl.43, 5456–5464 (2004).
   PubMed Web of Science ®Google Scholar
• Mackeyev Y , HartmanKB, AnantaJS, LeeAV, WilsonLJ. Catalytic synthesis of amino acid and peptide derivatized gadonanotubes.J. Am. Chem. Soc.131, 8342 (2009).
   PubMed Web of Science ®Google Scholar
• Langer M , KratzF, Rothen-RutishauserB, Wunderli-AllenspachH, Beck-SickingerAG. Novel peptide conjugates for tumor-specific chemotherapy.J. Med. Chem.44, 1341–1348 (2001).
   PubMed Web of Science ®Google Scholar
• Hassan AA , ChanBT, TranLAet al. Serine-derivatized gadonanotubes as magnetic nanoprobes for intracellular labeling. Contrast Media Mol. Imaging DOI: 10.1002/cmmi.293 (2009) (Epub ahead of print).
   Web of Science ®Google Scholar
• Grobner T . Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrol. Dial. Transplant.21, 1104–1108 (2006).
   PubMed Web of Science ®Google Scholar
• Grobner T , PrischlFC. Gadolinium and nephrogenic systemic fibrosis.Kidney Int.72, 260–264 (2007).
   PubMed Web of Science ®Google Scholar
• High WA , AyersRA, ChandlerJ, ZitoG, CowperSE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.J. Am. Acad. Dermatol.56, 21–26 (2007).
   PubMed Web of Science ®Google Scholar
• Thakral C , AbrahamJL. Nephrogenic systemic fibrosis: histology and gadolinium detection.Radiol. Clin. North Am.47, 841–846 (2009).
   PubMed Web of Science ®Google Scholar
• Todd DJ , KaganA, ChibnikLB, KayJ. Cutaneous changes of nephrogenic systemic fibrosis - Predictor of early mortality and association with gadolinium exposure.Arthritis Rheum.56, 3433–3441 (2007).
   PubMedGoogle Scholar
• Winter TC , FreenyPC, NghiemHVet al. MR-Imaging with IV-superparamagnetic iron-oxide – efficacy in the detection of focal hepatic-lesions. Am. J. Roentgenol. 161, 1191–1198 (1993).
   PubMed Web of Science ®Google Scholar

Website

• Latest IMV market report shows MRI procedure growth slowing to 3% per year. IMV Technologies. Press Release (2008). www.imvinfo.com/index.asp?Sec=abt&Sub=prs&Pag=dis&ItemId=200242
   Google Scholar